Singapore markets open in 6 hours 5 minutes

Straits Times Index
3,322.08
-8.69(-0.26%)
S&P 500
5,357.82
+10.83(+0.20%)
Dow
38,850.50
+51.51(+0.13%)
Nasdaq
17,177.14
+44.02(+0.26%)
Bitcoin USD
69,892.55
+189.18(+0.27%)
CMC Crypto 200
1,446.81
+0.14(+0.01%)

LLY Jun 2024 930.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

1.3700

-0.2100

(-13.29%)

As of 01:49PM EDT. Market open.

Loading interactive chart…

Yahoo Finance
Eli Lilly exec on weight-loss drugs: 'It's not just a flash in the pan'
Eli Lilly may be riding high on its diabetes and weight-loss treatments Mounjaro and Zepbound — which Wall Street estimates could net the company $13.5 billion in 2024 — but the success comes with ongoing criticism about pricing and access.
Zacks
Biogen (BIIB) & Eisai's Leqembi sBLA Gets FDA Acceptance
FDA accepts Biogen's (BIIB) partner Eisai's sBLA for a maintenance intravenous dosing version of Alzheimer's drug Leqembi. The final FDA decision is expected on Jan 25, 2025.
Zacks
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.